Vaccines

Primary tabs

Thu, 2015-01-08 20:48 — mdmcdonald

Information on vaccines to counter Ebola and other diseases

The Mission of this group is to follow the development of vaccines and other medications to counter Ebola and other diseases.

Add Content to this group

Click to add a new Group Post Simple to this group
Click to add a new Group Post Simple w Images to this group
Click to add a new Group Post to this group
Click to add a new PRIVATE Group Post to this group
Click to add a new TASK to this group

Members

Kathy Gilbeaux

mdmcdonald

MDMcDonald_me_com

mike kraft

Subscribe to group

Email address for group

vaccines_global@m.resiliencesystem.org

OVERVIEW: U.S. and International

Tue, 2021-02-23 10:39 — mike kraft

U.S and international COVID-related developments

ALSO SEE: Reuters worldwide roundup

SACRAMENTO, Calif. -- California lawmakers have cleared the way for 5.7 million people to get at least $600 in one-time payments, part of a state-sized coronavirus relief package aimed at helping lower-income people weather what they hope is the last legs of the pandemic.

The state Legislature passed the bill by a wide margin on Monday...

BUDAPEST — Officials in Hungary are urging people to trust in the vaccines already approved by the country ahead of a planned rollout Wednesday of a COVID-19 vaccine developed in China.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about OVERVIEW: U.S. and International
Log in or register to post comments

240 million vaccine doses expected for the US by end of March --Pharm company testimony

Tue, 2021-02-23 10:14 — mike kraft

Pharmaceutical companies pledge 240 million vaccine doses for the US by end of March The United States can expect to see a total of 240 million doses of Covid-19 vaccine by the end of March, according to prepared remarks drug companies will deliver to a House subcommittee today. The vaccine makers are set to testify at 10:30 a.m. ET. By <a href="/profiles/helen-regan">Helen Regan</a>, Eoin McSweeney and Ed Upright, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about 240 million vaccine doses expected for the US by end of March --Pharm company testimony
Log in or register to post comments

FDA new guidance: Vaccines Adapted for Variants Will Not Need Lengthy Testing

Tue, 2021-02-23 10:04 — mike kraft

The Food and Drug Administration said on Monday that vaccine developers would not need to conduct lengthy randomized controlled trials for vaccines that have been adapted to protect against concerning coronavirus variants.

The recommendations, which call for small trials more like those required for annual flu vaccines, would greatly accelerate the review process at a time when scientists are increasingly anxious about how the variants might slow or reverse progress made against the virus.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about FDA new guidance: Vaccines Adapted for Variants Will Not Need Lengthy Testing
Log in or register to post comments

TheHill.com Johnson & Johnson ready to provide doses for 20M Americans by end of March

Mon, 2021-02-22 20:14 — mike kraft

Johnson & Johnson ready to provide doses for 20M Americans by end of Johnson & Johnson said Monday that it plans to have enough doses of its vaccine for more than 20 million Americans by the end of March if its vaccine is authorized by the Food and Drug Administration. Peter Sullivan TheHill

Johnson & Johnson said Monday that it plans to have enough doses of its vaccine for more than 20 million Americans by the end of March if its vaccine is authorized by the Food and Drug Administration.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about TheHill.com Johnson & Johnson ready to provide doses for 20M Americans by end of March
Log in or register to post comments

Differences between COVID-19 vaccines, summarized in a simple table

Mon, 2021-02-22 20:02 — mike kraft

All the differences between COVID-19 vaccines, summarized in a simple table that you can take to your vaccination appointment This summary table shows the differences among the COVID-19 vaccines from Pfizer-BioNTech, Moderna, and AstraZeneca-Oxford University. Dr. Catherine Schuster-Bruce Business Insider

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Differences between COVID-19 vaccines, summarized in a simple table
Log in or register to post comments

British data study says COVID-19 vaccines sharply cut hospitalizations

Mon, 2021-02-22 18:11 — mike kraft

LONDON (AP) — Two U.K. studies released Monday showed that COVID-19 vaccination programs are contributing to a sharp drop in hospitalizations, boosting hopes that the shots will work as well in the real world as they have in carefully controlled studies.

Preliminary results from a study in Scotland found that the Pfizer-BioNTech vaccine reduced hospital admissions by up to 85% four weeks after the first dose, while the Oxford-AstraZeneca shot cut admissions by up to 94%. In England, preliminary data from a study of health care workers showed that the Pfizer vaccine reduced the risk of catching COVID-19 by 70% after one dose, a figure that rose to 85% after the second.

“This new evidence shows that the jab protects you, and protects those around you,” U.K. Health Secretary Matt Hancock said. “It is important that we see as much evidence as possible on the vaccine’s impact on protection and on transmission and we will continue to publish evidence as we gather it.’’

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about British data study says COVID-19 vaccines sharply cut hospitalizations
Log in or register to post comments

How efforts work in one Florida community to enroll people for coronavirus vaccines

Mon, 2021-02-22 12:23 — mike kraft

In one Florida community, enrolling people for coronavirus vaccines, one conversation at a time Those conversations are especially crucial in communities of color, where the virus has carved a vast path of destruction during the past year. Lori Rozsa Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about How efforts work in one Florida community to enroll people for coronavirus vaccines
Log in or register to post comments

Second-Shot Crunch Leaves Many Without Complete Immunizations

Mon, 2021-02-22 10:48 — mike kraft

Second-Shot Crunch Leaves Many Without Complete Immunizations John Tozzi Bloomberg.com

Almost a month after U.S. vaccination campaigns ramped up to give Covid-19 shots to more than a million people a day, their second doses are coming due, straining state rollouts and and leaving some without complete immunizations.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Second-Shot Crunch Leaves Many Without Complete Immunizations
Log in or register to post comments

Biden administration changes Trump administration priorities for vaccine distribution

Mon, 2021-02-22 10:10 — mike kraft

Biden upends Trump's calculation of who gets federal vaccination help This time, vaccines and supplies are going to underserved communities. "Anything Trump did, we're doing the opposite," said one official. NBC News

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Biden administration changes Trump administration priorities for vaccine distribution
Log in or register to post comments

Identifying and coping with those hesitant to take covid vaccine shots

Sun, 2021-02-21 13:11 — mike kraft

Breaking down the psychology of vaccine hesitancy Identifying the psychological barriers to taking vaccines is key to reaching the vaccine-hesitant. Bryan Walsh Axios

A new survey identifies some of the psychological barriers to taking vaccines — and how to overcome them.

The big picture: With COVID vaccine production and distribution ramping up, we're going to reach a moment when supply exceeds demand, which puts a premium on finding ways to persuade the persuadable on the value of vaccines.

Country / Region Tags:

General Topic Tags: